These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38744245)

  • 1. Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer.
    Dyikanov D; Zaitsev A; Vasileva T; Wang I; Sokolov AA; Bolshakov ES; Frank A; Turova P; Golubeva O; Gantseva A; Kamysheva A; Shpudeiko P; Krauz I; Abdou M; Chasse M; Conroy T; Merriam NR; Alesse JE; English N; Shpak B; Shchetsova A; Tikhonov E; Filatov I; Radko A; Bolshakova A; Kachalova A; Lugovykh N; Bulahov A; Kilina A; Asanbekov S; Zheleznyak I; Skoptsov P; Alekseeva E; Johnson JM; Curry JM; Linnenbach AJ; South AP; Yang E; Morozov K; Terenteva A; Nigmatullina L; Fastovetz D; Bobe A; Balabanian L; Nomie K; Yong ST; Davitt CJH; Ryabykh A; Kudryashova O; Tazearslan C; Bagaev A; Fowler N; Luginbuhl AJ; Ataullakhanov RI; Goldberg MF
    Cancer Cell; 2024 May; 42(5):759-779.e12. PubMed ID: 38744245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers.
    Korlimarla A; Ps H; Prabhu J; Ragulan C; Patil Y; Vp S; Desai K; Mathews A; Appachu S; Diwakar RB; Bs S; Melcher A; Cheang M; Sadanandam A
    Transl Oncol; 2022 Nov; 25():101511. PubMed ID: 35964339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
    Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
    Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker.
    Akyüz N; Brandt A; Stein A; Schliffke S; Mährle T; Quidde J; Goekkurt E; Loges S; Haalck T; Ford CT; Asemissen AM; Thiele B; Radloff J; Thenhausen T; Krohn-Grimberghe A; Bokemeyer C; Binder M
    Int J Cancer; 2017 Jun; 140(11):2535-2544. PubMed ID: 27925177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC).
    Chen HX; Song M; Maecker HT; Gnjatic S; Patton D; Lee JJ; Adam SJ; Moravec R; Liu XS; Cerami E; Lindsay J; Tang M; Hodi FS; Wu CJ; Wistuba II; Al-Atrash G; Bernatchez C; Bendall SC; Hewitt SM; Sharon E; Streicher H; Enos RA; Bowman MD; Tatard-Leitman VM; Sanchez-Espiridion B; Ranasinghe S; Pichavant M; Del Valle DM; Yu J; Janssens S; Peterson-Klaus J; Rowe C; Bongers G; Jenq RR; Chang CC; Abrams JS; Mooney M; Doroshow JH; Harris LN; Thurin M
    Clin Cancer Res; 2021 Sep; 27(18):5038-5048. PubMed ID: 33419780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies and Techniques for NK Cell Phenotyping.
    Ziqing C; Lundqvist A; Witt K
    Methods Mol Biol; 2019; 2032():105-114. PubMed ID: 31522415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5 signature genes revealed by single-cell profiling identified unique immune subtypes affecting the prognosis of ovarian cancer.
    Xiang SY; Li QK; Yang Z; Yi Q
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):2051-2062. PubMed ID: 38497886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of Single-Cell Omics in Tumor Immunology.
    Liu J; Qu S; Zhang T; Gao Y; Shi H; Song K; Chen W; Yin W
    Front Immunol; 2021; 12():697412. PubMed ID: 34177965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of the molecular mechanisms, immunological features and immunotherapy response of ferroptosis regulators across 33 cancer types.
    Tang B; Yan R; Zhu J; Cheng S; Kong C; Chen W; Fang S; Wang Y; Yang Y; Qiu R; Lu C; Ji J
    Int J Biol Sci; 2022; 18(1):180-198. PubMed ID: 34975326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrogating the Tumor Microenvironment by Deep Tissue Immunoprofiling.
    Llosa N
    Methods Mol Biol; 2022; 2435():139-156. PubMed ID: 34993944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer.
    Holl EK; Frazier VN; Landa K; Beasley GM; Hwang ES; Nair SK
    Front Immunol; 2019; 10():1767. PubMed ID: 31417550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Performance of a CD8 Gene Signature for Characterizing Inflammation in the Tumor Microenvironment across Multiple Tumor Types.
    Szabo PM; Pant S; Ely S; Desai K; Anguiano E; Wang L; Edwards R; Green G; Zhang N
    J Mol Diagn; 2021 Sep; 23(9):1159-1173. PubMed ID: 34197924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
    Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
    Front Immunol; 2021; 12():693062. PubMed ID: 34497605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade.
    Shen R; Postow MA; Adamow M; Arora A; Hannum M; Maher C; Wong P; Curran MA; Hollmann TJ; Jia L; Al-Ahmadie H; Keegan N; Funt SA; Iyer G; Rosenberg JE; Bajorin DF; Chapman PB; Shoushtari AN; Betof AS; Momtaz P; Merghoub T; Wolchok JD; Panageas KS; Callahan MK
    Sci Transl Med; 2021 Aug; 13(608):. PubMed ID: 34433638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dimensional Cytometry (ExCYT) and Mass Spectrometry of Myeloid Infiltrate in Clinically Localized Clear Cell Renal Cell Carcinoma Identifies Novel Potential Myeloid Targets for Immunotherapy.
    Theodros D; Murter BM; Sidhom JW; Nirschl TR; Clark DJ; Chen L; Tam AJ; Blosser RL; Schwen ZR; Johnson MH; Pierorazio PM; Zhang H; Ganguly S; Pardoll DM; Zarif JC
    Mol Cell Proteomics; 2020 Nov; 19(11):1850-1859. PubMed ID: 32737216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
    Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H
    Front Immunol; 2021; 12():769425. PubMed ID: 34804059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-Infiltrating Immune Cell-Based Subtyping and Signature Gene Analysis in Breast Cancer Based on Gene Expression Profiles.
    Jiang J; Pan W; Xu Y; Ni C; Xue D; Chen Z; Chen W; Huang J
    J Cancer; 2020; 11(6):1568-1583. PubMed ID: 32047563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development.
    Lin H; Wang K; Xiong Y; Zhou L; Yang Y; Chen S; Xu P; Zhou Y; Mao R; Lv G; Wang P; Zhou D
    Front Immunol; 2022; 13():773264. PubMed ID: 35185876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.